Myda Advisors LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Myda Advisors LLC

  • $407 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $8.61 Million - $10.9 Million
-18,000 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $2.18 Million - $2.63 Million
-4,000 Reduced 18.18%
18,000 $10.1 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $7.89 Million - $10.3 Million
16,000 Added 266.67%
22,000 $13.7 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $2.02 Million - $2.97 Million
6,000 New
6,000 $2.93 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email